Paragon Capital Management (Utah)’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,576	Closed	-$1.03M	–	83
2022 Q4	$1.03M	Sell	3,576 -2,559	-42%	-$739K	0.96%	45
2022 Q3	$1.78M	Sell	6,135 -37	-0.6%	-$10.7K	1.74%	13
2022 Q2	$1.74M	Buy	+6,172	New	+$1.74M	1.76%	14